Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
10.04
+0.96 (10.57%)
At close: Nov 21, 2025, 4:00 PM EST
10.08
+0.04 (0.40%)
Pre-market: Nov 24, 2025, 5:37 AM EST
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Emergent BioSolutions stock has a target of 15, which predicts a 49.40% increase from the current stock price of 10.04.
Price Target: $15 (+49.40%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 3, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Emergent BioSolutions is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +49.40% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +49.40% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +49.40% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +49.40% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +49.40% | Jan 21, 2025 |
Financial Forecast
Revenue This Year
815.98M
from 1.04B
Decreased by -21.81%
Revenue Next Year
941.83M
from 815.98M
Increased by 15.42%
EPS This Year
2.07
from -3.60
EPS Next Year
-0.45
from 2.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | 864.2M | 1.2B | ||
| Avg | 816.0M | 941.8M | ||
| Low | 775.3M | 695.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | -17.2% | 48.7% | ||
| Avg | -21.8% | 15.4% | ||
| Low | -25.7% | -14.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.15 | -0.47 | |
| Avg | 2.07 | -0.45 | |
| Low | 2.01 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.